Alto Neuroscience (ANRO) PT Lowered to $36 at Baird

May 18, 2026 7:32 AM

Baird analyst Brian Skorney lowered the price target on Alto Neuroscience (NYSE: ANRO) to $36.00 (from $38.00) while maintaining a Outperform rating.

No results found